Drug policy and harm reduction: impact of the US policy Raminta Stuikyte Central and Eastern European Harm Reduction Network.

Slides:



Advertisements
Similar presentations
HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS.
Advertisements

HIV and Harm Reduction Winning on policy front : Faltering on Implementation JVR Prasada Rao, UNAIDS XVIII International Harm Reduction Conference Warsaw,
SGA1 – The evolving role of UNAIDS in a changing financial environment UNAIDS has adapted to a new funding environment and developed strong and positive.
Scaling Up HIV Prevention among IDUs in South Asia: the key issues & gaps Dr. M. Suresh Kumar MD DPM MPH Chennai India Inter-country Consultation on Preventing.
Unprevented and prevented HIV cases in Europe and Central Asia Unprevented and prevented HIV cases in Europe and Central Asia Ani SHAKARISHVILI, MD UNAIDS.
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
Bringing Opioid Substitution Treatment to scale Dr. M. Suresh Kumar Inter-country Consultation on Preventing HIV among IDUs Scaling Up: From Evidence to.
Supporting community action on AIDS in developing countries NO voice NO programs: V ulnerable communities in the EECA region Developed in collaboration.
Hepatitis C Action Plan Prevention Working Group Findings and recommendations Norah Palmateer Health Protection Scotland Greater Glasgow & Clyde MCN June.
Cost-Effectiveness of Needle Exchange Program among IDUs in Uzbekistan Azizbek A. Boltaev IREX Contemporary Issues Program Fellow Dynamic Communications:
HIV, Drugs & Prisons Photo by Mr. Alessandro Scotti, UNODC Good Will Ambassador Gino Vumbaca.
Doing the Right Thing Karen A. Stanecki XV International AIDS Conference.
1 Johannesburg June 2014 Impact of legal aid programmes for persons with HIV, drug users and other affected populations.
…at what cost ? …at what cost ?. Ten year review:  Law enforcement at the expense of public health and human rights  Major HIV epidemics among IDU 
How to survive in a non-supportive environment: Experience from Russia Ivan Varentsov (Andrey Rylkov Foundation) AIDS 2014, Melbourne.
Dr Fabienne Hariga Senior Adviser UNODC HIV Section, Vienna 27 May 2014 Mandates, missions, roles and responsibilities & relation to health in prisons.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
HIV, Drug Policy and Harm Reduction. Outreach in Moscow, Russia,1998.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
COUNTRY PRESENTATION (DRUGS AND HIV/AIDS)– Nepal Dr. Krishna Kumar Rai, Director National Centre for AIDS and STD Control, Ministry of Health and Population.
Advocating for Harm Reduction: A Public Health Response to Drug Use and HIV in Eastern Europe and Central Asia Sue Simon International Harm Reduction Development.
1 Current status of harm reduction in Asia International AIDS Conference, Toronto, August 2006 Mr Jimmy Dorabjee Macfarlane Burnet Institute, Melbourne,
1 Controlling HIV among injecting drug users: current status of harm reduction International AIDS Conference, Toronto, 15 August 2006 Dr. Alex Wodak, Sydney,
HIV and AIDS Data Hub for Asia-Pacific Review in slides Key Affected Populations.
Medical Professionalism and its Relationship to Public Health: Physician Advocacy and State Public Health Policy Thomas Kellogg Program Officer and Advisor.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
A global perspective on scaling up harm reduction 2 nd National Harm Reduction Conference, Ukraine, March 2007 Dr Jos Perriens, Director Prevention.
Resource Needs Model Rachel Sanders October 28 th, 2010.
POLICE LEADERSHIP IN THE HIV RESPONSE IN VIETNAM CLEPH-IDLO Satellite Session Law Enforcement and HIV Network ICAAP 11, 2013, Bangkok, Thailand LAM TIEN.
National roll-out of database for HIV prevention programmes among civil society organizations in Ukraine Olga Varetska ICF “International HIV/AIDS Alliance.
1 HIV and AIDS Data Hub for Asia-Pacific Review in slides Bangladesh.
Harm Reduction International
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
How to improve law enforcement knowledge about HIV and to work with drug users and sex workers: experiences from Kyrgyzstan Aleksandr Zelichenko, Director.
Knowing your Epidemic: Designing Better Interventions in Prisons Deputy Commissioner Mary C. Chepkonga Kenya Prisons Service International AIDS Conference.
Key Affected Populations in Asia: Where are we and what is the way forward? Dr. Sai Subhasree Raghavan SAATHII, India Governing Council Member, IAS.
Prevention of HIV infection: How effectively are countries responding to changing epidemics in the Asia Pacific Region? 1.
Working Group on Most at Risk Young People Achievements, Challenges and Priorities IATT HIV and Young People April 2009.
HIV/AIDS in Eastern Europe Setting the Stage for Prevention HIV/AIDS in Eastern Europe Setting the Stage for Prevention Thomas E. Novotny, MD, MPH April.
HIV Prevention, Treatment and Care in Prisons and other Closed Settings Ehab Salah Prisons and HIV Advisor UNODC, Vienna ICASA 2015 Harare, Zimbabwe 2.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: January 2016.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Myanmar Last Update: June 2015.
From evidence to commitment to action: implementing HIV prevention measures in prisons in Ukraine XVI International AIDS Conference Toronto, 15 August.
Law Enforcement agencies and civil society organizations: critical partners in HIV services provision for people who use drugs Zhannat Kosmukhamedova,
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan.
Edo Agustian Indonesian Drug Users Network Meaningful Involvement of PWID in Hep C advocacy in Indonesia.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: November 2014.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
BURUNDI PERMANENT EXECUTIVE SECRETARIAT (SEP) NATIONAL AIDS COUNCIL (C N L S) Epidemic situation and national response for prevention in Burundi PRESENTED.
MODULE 3 Harm reduction advocacy
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
WHO’s policy priorities and projects
Fabienne Hariga Senior Adviser, HIV/AIDS Section
Opportunities and prospects.
Needle and syringe exchange and working with injecting drug users
Harm reduction: decriminalising drug use in Asia
The Efficacy of RN Supervised Safe Injection Sites
Pakistan Last updated: July 2015.
Addressing Drug Use Together Through a Health Based Approach:
Key Affected Populations
People who inject drugs
08 Uniting the World against AIDS Introduction
Towards a Conducive Legal and Structural Environment
Showing throughout the event
The View from Ottawa.
The HIV Epidemic among People who Inject Drugs
ENDING THE EPIDEMICS: A FOCUS ON PEOPLE WHO INJECT DRUGS
Myanmar Last Update: November 2014.
Key Affected Populations
Presentation transcript:

Drug policy and harm reduction: impact of the US policy Raminta Stuikyte Central and Eastern European Harm Reduction Network

The US on drugs and harm reduction Federal ban to buy needles and syringes using federal money (for programs and for research) Guidance on the Definition and Use of the Child Survival and Health Programs Fund and the Global HIV/AIDS Initiative Account, USAID, 2004 Promotion of war on drugs At least 7 federally-funded reviews and reports conducted by public health officials, researchers and US government agencies have concluded that syringe exchange programs are effective, safe and cost effective. Letter of over 130 diverse individuals and organizations in the USA to US Ambassador to Combat HIV/AIDS Globally; May 2005

In the US Needle exchange is not funded through federal money –A number of states, cities and private donors are funding needle exchange –In 2002, 25 million needles and syringes distributed for population of about 290m In Australia (population=20m), 32m needles and syringes distributed War on Drugs: –The number of incarcerated drug offenders has increased 12-fold since 1980 –22% of people incarcerated charged for drug offences –No substitution treatment in federal prisons –Some jails do have substitution treatment –No needle exchange in prisons and jails

Affects on US-funded programs Major revisions in 2004 Revisions of publications and removing references to harm reduction Revisions of programs In some cases, programs –the US money for salaries and infrastructure –needles/syringes from other sources if there were replacing funds

Context of the US drugs/AIDS policy affects on other countries There is still lacking understanding of harm reduction in the world A number of governments look to the United States for guidance about how best to respond to the HIV/AIDS epidemic

The US and the UN UN AIDS policy framework: UNAIDS Prevention Policy –for 12 months the US pushed to remove references to harm reduction and needle exchange –Reservation of the US in adopted document 2005 UN drug policy framework –The US is major funder of UN agency on drugs UNODC –2004: US high level official threatened UNODC chief to cut funding to UNODC unless he assured that UNODC would abstain from any involvement in or expression of support for harm reduction, including needle exchange. –No references to needle exchange and harm reduction in UNODC documents and pubic statements since that time

The US and developing countries The harshest affect on countries with major HIV epidemics among injecting drug users (IDUs), –esp in Asia where FHI/USAID was key funder of HIV prevention among IDUs Indonesia: –the government marked harm reduction as a key HIV prevention priority. The collaboration with FHI (financially supported by USAID) and Indonesian partners have had to review programs and projects since FHI could no longer support harm reduction activities. Some projects were halted while other were temporarily suspended.

Thailand: –War on Drugs announced in 2003 extra-judicial assassination of over 2,200 drug users –War on Drugs reannounced and continued in 2004 and so on –No needle exchange; limited and hardly accessible one methadone program Uzbekistan: –A project in Tashkent reported that 30% of over 1,400 sex worker clients are also IDUs, and that 30% had acknowledged sharing needles and syringes. The project had not initiated needle/syringe exchange because it received the bulk of its funding from USAID, which does not permit the use of its funds for such activities.

Conclusions The policies of external donors can have a disproportionate impact on harm reduction projects in countries where national or local governments provide little or no funding for them. The US policy on drugs and harm reduction is fueling HIV in countries with injecting drug use- driven epidemics, where it is essential to have wide scale harm reduction (evidence based, relatively low-cost and not requiring strong health/social infrastructure strategies).